Search

everythinglearnresearchcommunity

for

Search:↓

Promising cancer treatments were found, but the manufacturer closed.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

Medicinal plants have potential as alternative cancer treatments due to their ability to target and kill cancer cells.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Suppressing certain hormones might help prevent prostate cancer.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Higher doses of cranial irradiation are linked to permanent hair loss.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.